The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts. / Aplin, Mark; Christensen, Gitte Lund; Schneider, Mikael; Heydorn, Arne; Gammeltoft, Steen; Kjølbye, Anne Louise; Sheikh, Søren P; Hansen, Jakob Lerche.
In: Basic & Clinical Pharmacology & Toxicology, Vol. 100, No. 5, 05.2007, p. 289-95.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts
AU - Aplin, Mark
AU - Christensen, Gitte Lund
AU - Schneider, Mikael
AU - Heydorn, Arne
AU - Gammeltoft, Steen
AU - Kjølbye, Anne Louise
AU - Sheikh, Søren P
AU - Hansen, Jakob Lerche
PY - 2007/5
Y1 - 2007/5
N2 - The angiotensin II (AngII) type 1 receptor (AT(1)R) has been shown to activate extracellular signal-regulated kinases 1 and 2 (ERK1/2) through G proteins or G protein-independently through beta-arrestin2 in cellular expression systems. As activation mechanisms may greatly influence the biological effects of ERK1/2 activity, differential activation of the AT(1)R in its native cellular context could have important biological and pharmacological implications. To examine if AT(1)R activates ERK1/2 by G protein-independent mechanisms in the heart, we used the [Sar(1), Ile(4), Ile(8)]-AngII ([SII] AngII) analogue in native preparations of cardiac myocytes and beating hearts. We found that [SII] AngII does not activate G(q)-coupling, yet stimulates the beta-arrestin2-dependent ERK1/2. The G(q)-activated pool of ERK1/2 rapidly translocates to the nucleus, while the beta-arrestin2-scaffolded pool remains in the cytosol. Similar biased agonism was achieved in Langendorff-perfused hearts, where both agonists elicit ERK1/2 phosphorylation, but [SII] AngII induces neither inotropic nor chronotropic effects.
AB - The angiotensin II (AngII) type 1 receptor (AT(1)R) has been shown to activate extracellular signal-regulated kinases 1 and 2 (ERK1/2) through G proteins or G protein-independently through beta-arrestin2 in cellular expression systems. As activation mechanisms may greatly influence the biological effects of ERK1/2 activity, differential activation of the AT(1)R in its native cellular context could have important biological and pharmacological implications. To examine if AT(1)R activates ERK1/2 by G protein-independent mechanisms in the heart, we used the [Sar(1), Ile(4), Ile(8)]-AngII ([SII] AngII) analogue in native preparations of cardiac myocytes and beating hearts. We found that [SII] AngII does not activate G(q)-coupling, yet stimulates the beta-arrestin2-dependent ERK1/2. The G(q)-activated pool of ERK1/2 rapidly translocates to the nucleus, while the beta-arrestin2-scaffolded pool remains in the cytosol. Similar biased agonism was achieved in Langendorff-perfused hearts, where both agonists elicit ERK1/2 phosphorylation, but [SII] AngII induces neither inotropic nor chronotropic effects.
KW - 1-Sarcosine-8-Isoleucine Angiotensin II
KW - Angiotensin II
KW - Animals
KW - Animals, Newborn
KW - Arrestins
KW - Cell Nucleus
KW - Cells, Cultured
KW - Coronary Circulation
KW - Cytosol
KW - GTP-Binding Proteins
KW - Heart Rate
KW - Heart Ventricles
KW - Male
KW - Mitogen-Activated Protein Kinase 1
KW - Mitogen-Activated Protein Kinase 3
KW - Muscle Contraction
KW - Myocardium
KW - Myocytes, Cardiac
KW - Perfusion
KW - Rats
KW - Rats, Sprague-Dawley
KW - Rats, Wistar
KW - Receptor, Angiotensin, Type 1
U2 - 10.1111/j.1742-7843.2007.00063.x
DO - 10.1111/j.1742-7843.2007.00063.x
M3 - Journal article
C2 - 17448113
VL - 100
SP - 289
EP - 295
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
SN - 1742-7835
IS - 5
ER -
ID: 34167892